These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 30041625)

  • 21. Memantine treatment in patients with mild to moderate Alzheimer's disease: results of a randomised, double-blind, placebo-controlled 6-month study.
    Bakchine S; Loft H
    J Alzheimers Dis; 2008 Feb; 13(1):97-107. PubMed ID: 18334761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model.
    Bond M; Rogers G; Peters J; Anderson R; Hoyle M; Miners A; Moxham T; Davis S; Thokala P; Wailoo A; Jeffreys M; Hyde C
    Health Technol Assess; 2012; 16(21):1-470. PubMed ID: 22541366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific functional effects of memantine treatment in patients with moderate to severe Alzheimer's disease.
    Doody R; Wirth Y; Schmitt F; Möbius HJ
    Dement Geriatr Cogn Disord; 2004; 18(2):227-32. PubMed ID: 15256834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative safety and effectiveness of cholinesterase inhibitors and memantine for Alzheimer's disease: a network meta-analysis of 41 randomized controlled trials.
    Dou KX; Tan MS; Tan CC; Cao XP; Hou XH; Guo QH; Tan L; Mok V; Yu JT
    Alzheimers Res Ther; 2018 Dec; 10(1):126. PubMed ID: 30591071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A 24-week randomized, controlled trial of memantine in patients with moderate-to-severe Alzheimer disease.
    van Dyck CH; Tariot PN; Meyers B; Malca Resnick E;
    Alzheimer Dis Assoc Disord; 2007; 21(2):136-43. PubMed ID: 17545739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trial.
    Porsteinsson AP; Grossberg GT; Mintzer J; Olin JT;
    Curr Alzheimer Res; 2008 Feb; 5(1):83-9. PubMed ID: 18288936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial.
    Tariot PN; Farlow MR; Grossberg GT; Graham SM; McDonald S; Gergel I;
    JAMA; 2004 Jan; 291(3):317-24. PubMed ID: 14734594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monotherapy Is Good Enough for Patients with Mild-to-Moderate Alzheimer's Disease: A Network Meta-analysis of 76 Randomized Controlled Trials.
    Tsoi KK; Chan JY; Chan FC; Hirai HW; Kwok TC; Wong SY
    Clin Pharmacol Ther; 2019 Jan; 105(1):121-130. PubMed ID: 29717478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT.
    Jones R; Sheehan B; Phillips P; Juszczak E; Adams J; Baldwin A; Ballard C; Banerjee S; Barber B; Bentham P; Brown R; Burns A; Dening T; Findlay D; Gray R; Griffin M; Holmes C; Hughes A; Jacoby R; Johnson T; Jones R; Knapp M; Lindesay J; McKeith I; McShane R; Macharouthu A; O'Brien J; Onions C; Passmore P; Raftery J; Ritchie C; Howard R;
    Trials; 2009 Jul; 10():57. PubMed ID: 19630974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Memantine: a review of its use in Alzheimer's disease.
    Robinson DM; Keating GM
    Drugs; 2006; 66(11):1515-34. PubMed ID: 16906789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of memantine to treat Alzheimer's disease.
    Gauthier S; Herrmann N; Ferreri F; Agbokou C
    CMAJ; 2006 Aug; 175(5):501-2. PubMed ID: 16940271
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluating high-dose rivastigmine patch in severe Alzheimer's disease: analyses with concomitant memantine usage as a factor.
    Grossberg GT; Farlow MR; Meng X; Velting DM
    Curr Alzheimer Res; 2015; 12(1):53-60. PubMed ID: 25523430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis.
    Tan CC; Yu JT; Wang HF; Tan MS; Meng XF; Wang C; Jiang T; Zhu XC; Tan L
    J Alzheimers Dis; 2014; 41(2):615-31. PubMed ID: 24662102
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Memantine for Alzheimer's disease.
    Med Lett Drugs Ther; 2003 Sep; 45(1165):73-4. PubMed ID: 12968123
    [No Abstract]   [Full Text] [Related]  

  • 35. Acetylcholinesterase inhibitors combined with memantine for moderate to severe Alzheimer's disease: a meta-analysis.
    Glinz D; Gloy VL; Monsch AU; Kressig RW; Patel C; McCord KA; Ademi Z; Tomonaga Y; Schwenkglenks M; Bucher HC; Raatz H
    Swiss Med Wkly; 2019 Jun; 149():w20093. PubMed ID: 31269225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Memantine treatment for Japanese patients with moderate to severe Alzheimer's disease: a meta-analysis of double-blind, randomized, placebo-controlled trials.
    Kishi T; Matsunaga S; Iwata N
    Neuropsychiatr Dis Treat; 2018; 14():2915-2922. PubMed ID: 30464475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of memantine on cognition in patients with moderate to severe Alzheimer's disease: post-hoc analyses of ADAS-cog and SIB total and single-item scores from six randomized, double-blind, placebo-controlled studies.
    Mecocci P; Bladström A; Stender K
    Int J Geriatr Psychiatry; 2009 May; 24(5):532-8. PubMed ID: 19274640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of the effect of memantine in reducing the worsening of clinical symptoms in patients with moderate to severe Alzheimer's disease.
    Wilkinson D; Andersen HF
    Dement Geriatr Cogn Disord; 2007; 24(2):138-45. PubMed ID: 17622761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Concomitant Use of Cholinesterase Inhibitors or Memantine With Cognitive Decline in Alzheimer Clinical Trials: A Meta-analysis.
    Kennedy RE; Cutter GR; Fowler ME; Schneider LS
    JAMA Netw Open; 2018 Nov; 1(7):e184080. PubMed ID: 30646339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Memantine: a review of studies into its safety and efficacy in treating Alzheimer's disease and other dementias.
    Thomas SJ; Grossberg GT
    Clin Interv Aging; 2009; 4():367-77. PubMed ID: 19851512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.